Lead party: Egyptian-American Enterprise Fund (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Orchidia Pharmaceutical Industries S.A.E. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt
Transaction type: Investment, Exit · Asset class: Private Equity · Strategy: Secondary Sale · Instrument: Equity
Lead investor/buyer: Egyptian-American Enterprise Fund · Investors/buyers: Egyptian-American Enterprise Fund · Sellers: SPE Capital Partners
Legal advisers: not identified in the source record.
Source: announced 1 November 2017. Original announcement: africaglobalfunds.com.


